# FDA Inspection 905430 - Bloodline Holdings, LLC - November 17, 2014

Source: https://www.keypedia.com/records/fda_inspections/bloodline-holdings-llc/e48bc1a8-8120-4435-8e03-7f2a111f73e2
Source feed: FDA_Inspections

> FDA Inspection 905430 for Bloodline Holdings, LLC on November 17, 2014. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 905430
- Company Name: Bloodline Holdings, LLC
- Inspection Date: 2014-11-17
- Classification: Official Action Indicated (OAI)
- Project Area: Unapproved and Misbranded Drugs
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1107052 - 2019-09-25](https://www.keypedia.com/records/fda_inspections/bloodline-holdings-llc/c491ad84-441f-4014-bb50-a3023fb7f9a3)
- [FDA Inspection 965178 - 2016-03-17](https://www.keypedia.com/records/fda_inspections/bloodline-holdings-llc/2831e60b-4c59-48ac-8f06-ead3da723248)
- [FDA Inspection 905430 - 2014-11-17](https://www.keypedia.com/records/fda_inspections/bloodline-holdings-llc/d3ec83a8-f718-4ae6-bcbe-a3903a69aaa6)

Company: https://www.keypedia.com/companies/bloodline-holdings-llc/77815c55-ade4-4167-b9b4-8186a2d48587

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c